Last reviewed · How we verify

NCT04960436

Clinical Effect of Allogeneic Meniscus Transplantation

Completed NA Last updated 13 July 2021
What this trial tests

NA trial testing Meniscus Allograft Transplantation in Meniscus Lesion in 38 participants. Completed in 1 April 2021.

Timeline
1 February 2005
Primary endpoint
1 April 2021
1 April 2021

Quick facts

Lead sponsorPeking University Third Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment38
Start date1 February 2005
Primary completion1 April 2021
Estimated completion1 April 2021
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Peking University Third Hospital

Who can join

Adults 16 to 46, any sex, with Meniscus Lesion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, patients who underwent allogeneic meniscus transplantation and meniscus resection were followed up for more than 10years to evaluate the long-term efficacy and explore the cartilage protective role of meniscus transplantation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Meniscus Lesion

Currently open trials in the same condition.

Other Peking University Third Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04960436.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing